Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Storage and Handling Store both Cagrilintide and Retatrutide as lyophilized powder at -20C, protected from light and moisture
Superior and Sustained Performance: Arthramid achieves 80-85% efficacy across multiple peer-reviewed studies Long-lasting Results: Clinical studies demonstrate sustained efficacy up to 2 years post-treatment Evidence-Based Efficacy: Double-blinded controlled studies confirm Arthramid outperforms triamcinolone steroid and hyaluronic acid Proven Safety Profile: Histopathology studies confirm successful joint integration and biocompatibility Robust Research Foundation: Results validated across six independent peer-reviewed studies spanning multiple research teams and geographical locations Unlike many joint treatments on the market, Arthramid is backed by a growing body of robust, real-world research, not just anecdotal outcomes
Preclinical research demonstrates that BPC-157 supports tissue recovery by enhancing epithelial repair, stimulating angiogenesis, and modulating growth-related pathways, including the upregulation of vascular endothelial growth factor (VEGF)
Injection Timing No definitive evidence establishes optimal injection timing
US$ 24.64
US$ 20.82
US$ 21.06
US$ 27.79
US$ 22.05
US$ 27.24
US$ 26.71
